Acorah Software Products - Accounts Production 16.5.460 false true true 31 August 2024 1 September 2023 false 1 September 2024 31 August 2025 31 August 2025 12786185 Mr Shailesh Suri iso4217:GBP iso4217:EUR iso4217:USD xbrli:shares xbrli:pure xbrli:pure 12786185 2024-08-31 12786185 2025-08-31 12786185 2024-09-01 2025-08-31 12786185 frs-core:ComputerEquipment 2024-09-01 2025-08-31 12786185 frs-core:ShareCapital 2025-08-31 12786185 frs-core:RetainedEarningsAccumulatedLosses 2025-08-31 12786185 frs-bus:PrivateLimitedCompanyLtd 2024-09-01 2025-08-31 12786185 frs-bus:AbridgedAccounts 2024-09-01 2025-08-31 12786185 frs-bus:SmallEntities 2024-09-01 2025-08-31 12786185 frs-bus:AuditExempt-NoAccountantsReport 2024-09-01 2025-08-31 12786185 frs-bus:SmallCompaniesRegimeForAccounts 2024-09-01 2025-08-31 12786185 frs-bus:Director1 2024-09-01 2025-08-31 12786185 frs-countries:EnglandWales 2024-09-01 2025-08-31 12786185 2023-08-31 12786185 2024-08-31 12786185 2023-09-01 2024-08-31 12786185 frs-core:ShareCapital 2024-08-31 12786185 frs-core:RetainedEarningsAccumulatedLosses 2024-08-31
Registered number: 12786185
SAMBHAV HEALTH LTD
Unaudited ABRIDGED Financial Statements
For The Year Ended 31 August 2025
Contents
Page
Abridged Balance Sheet 1—2
Notes to the Abridged Financial Statements 3—4
Page 1
Abridged Balance Sheet
Registered number: 12786185
2025 2024
Notes £ £ £ £
FIXED ASSETS
Tangible Assets 4 - 252
- 252
CURRENT ASSETS
Debtors 16,360 30,159
Cash at bank and in hand - 514
16,360 30,673
Creditors: Amounts Falling Due Within One Year (13,471 ) (9,626 )
NET CURRENT ASSETS (LIABILITIES) 2,889 21,047
TOTAL ASSETS LESS CURRENT LIABILITIES 2,889 21,299
NET ASSETS 2,889 21,299
CAPITAL AND RESERVES
Called up share capital 5 100 100
Profit and Loss Account 2,789 21,199
SHAREHOLDERS' FUNDS 2,889 21,299
Page 1
Page 2
For the year ending 31 August 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
The member has not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The director acknowledges his responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.
The company has taken advantage of section 444(1) of the Companies Act 2006 and opted not to deliver to the registrar a copy of the company's Profit and Loss Account.
All of the company's members have consented to the preparation of an Abridged Balance Sheet for the year end 31 August 2025 in accordance with section 444(2A) of the Companies Act 2006.
On behalf of the board
Mr Shailesh Suri
Director
16/09/2025
The notes on pages 3 to 4 form part of these financial statements.
Page 2
Page 3
Notes to the Abridged Financial Statements
1. General Information
SAMBHAV HEALTH LTD is a private company, limited by shares, incorporated in England & Wales, registered number 12786185 . The registered office is 5-9 Headstone Road, Harrow, Middlesex, HA1 1PD.
2. Accounting Policies
2.1. Basis of Preparation of Financial Statements
The financial statements have been prepared under the historical cost convention and in accordance with Financial Reporting Standard 102 section 1A Small Entities "The Financial Reporting Standard applicable in the UK and Republic of Ireland" and the Companies Act 2006.
The financial statements are prepared in sterling, which is the functional currency of the company. Monetary amounts in these financial statements are rounded to the nearest £.
2.2. Going Concern Disclosure
At the time of approving the financial statements, the business activities for the company continue as normal. The company meets its day to day working capital requirements through continued support from the company's director. The financial statements are prepared on the going concern basis as support from the company's director to provide financial support to the company in order that it can continue to trade and meet its liabilities as they fall due. This support will continue for a period of at least 12 months from the date of approval of these financial statements. The financial statements do not include any adjustments that would result from a withdrawal of the facility by the company's director.
2.3. Turnover
Turnover is measured at the fair value of the consideration received or receivable, net of discounts and value added taxes. Turnover includes revenue earned from the rendering of services. Turnover is reduced for estimated customer returns, rebates and other similar allowances.
2.4. Tangible Fixed Assets and Depreciation
Tangible fixed assets are measured at cost less accumulated depreciation and any accumulated impairment losses. Depreciation is provided at rates calculated to write off the cost of the fixed assets, less their estimated residual value, over their expected useful lives on the following bases:
Computer Equipment St.line
2.5. Taxation
Income tax expense represents the sum of the tax currently payable.
The tax currently payable is based on taxable profit for the year. Taxable profit differs from profit as reported in the statement of comprehensive income because of items of income or expense that are taxable or deductible in other years and items that are never taxable or deductible. The company's liability for current tax is calculated using tax rates that have been enacted or substantively enacted by the end of the reporting period.
2.6. Pensions
The company operates a defined pension contribution scheme. Contributions are charged to the profit and loss account as they become payable in accordance with the rules of the scheme.
3. Average Number of Employees
Average number of employees, including directors, during the year was: 2 (2024: 2)
2 2
Page 3
Page 4
4. Tangible Assets
Total
£
Cost
As at 1 September 2024 2,455
As at 31 August 2025 2,455
Depreciation
As at 1 September 2024 2,203
Provided during the period 252
As at 31 August 2025 2,455
Net Book Value
As at 31 August 2025 -
As at 1 September 2024 252
5. Share Capital
2025 2024
£ £
Allotted, Called up and fully paid 100 100
Page 4